Stay updated on 24-Week Secukinumab Efficacy for Psoriatic Arthritis Clinical Trial
Sign up to get notified when there's something new on the 24-Week Secukinumab Efficacy for Psoriatic Arthritis Clinical Trial page.

Latest updates to the 24-Week Secukinumab Efficacy for Psoriatic Arthritis Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoNo Change Detected
- Check17 days agoChange Detected- Revision label updated from v3.4.3 to v3.5.0 on the page.SummaryDifference0.0%

- Check24 days agoNo Change Detected
- Check31 days agoChange DetectedSite revision updated from v3.4.2 to v3.4.3.SummaryDifference0.0%

- Check52 days agoChange DetectedMinor system update shows Revision: v3.4.2 replacing v3.4.1; no impact on study details, eligibility criteria, locations, or results. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check59 days agoChange DetectedThe page shows a revision update from v3.4.0 to v3.4.1; this appears to be a minor backend/version update with no changes to the study content or user-facing features. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check83 days agoChange Detected- Footer revision tag updated from v3.3.3 to v3.3.4.SummaryDifference0.0%

- Check104 days agoChange DetectedLocations data was updated with new site entries across several regions (e.g., Florida, Indiana, Kentucky, New Jersey, New York, etc., plus international regions), and some regional location subsections were removed/reorganized.SummaryDifference2%

Stay in the know with updates to 24-Week Secukinumab Efficacy for Psoriatic Arthritis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the 24-Week Secukinumab Efficacy for Psoriatic Arthritis Clinical Trial page.